product performance
The latest news about product performance: headlines, AI summaries and the full story from every source.
- Akebia Therapeutics Reports Q3 2026 Financial Results Amid Vafseo Growth and Auryxia Decline
- Amphastar Reports Q3 2026 Revenue Growth Driven by BAQSIMI and Primatene MIST Sales
- Xeris Biopharma Reports Q3 2026 Revenue Growth Driven by Recorlev
- Nuvation Bio Reports Q3 Revenue Growth Driven by IBTROZI Sales and Outlines European Expansion Plans
- UroGen Pharma Reports Strong Revenue Growth Driven by Zosturi Sales
- Harmony Biosciences Reports Q3 2026 Net Product Revenue of $268.9 Million Driven by WAKIX Growth
- Ardelyx Reports Q3 2026 Revenue Growth Driven by IBSRELA and XPHOZAH Demand
- Astera Labs Reports Record Q3 Revenue and Projects Strong Q4 Growth Driven by Scorpio X-Series
- Teva Pharmaceutical Industries Reports Q3 2026 Results with Raised Full-Year Guidance
- Cerus Reports Q3 2026 Revenue Growth Driven by INTERCEPT Fibrinogen Complex
- Jazz Pharmaceuticals Reports Q3 2026 Results with Revenue Growth and Raised Guidance
- Krystal Biotech Reports Q3 2026 Results with $127.3 Million VYJUVEK Revenue
- AbbVie Reports Q3 Earnings Beat Driven by Skyrizi and Rinvoq Growth
- Merck Raises Full-Year Outlook as New Drug Sales Offset Generic Losses
- Bristol-Myers Squibb Reports Q3 2026 Revenue Growth Driven by Growth Portfolio
- Biogen Reports Q3 2026 Revenue Growth Driven by Apellis Acquisition and Strong Growth Portfolio
- Adherex Technologies Expands PEDMARK's Reach into Larger AYA Market Following Record Q1 Revenue
- Ascendis Financials for Q1 2026: Revenue and Operating Performance
- Alcon Forecasts Sales Growth and Announces Share Repurchase Program
- Elanco Animal Health Reports Strong Q1 2026 Performance with Revenue Growth and Product Success
- Nuvation Bio Reports Q1 2026 Earnings with Revenue Growth and Patient Data
- Sonos Reports Q2 2026 Earnings with Revenue Growth and Margin Pressures
- Apple Reports Stronger-Than-Expected Mac Sales Driven by AI Demand
- Crocs Q1 2026 Earnings Call Summary: Strong DTC Performance and Strategic Growth Initiatives
- Altria Reports Strong Q1 2026 Performance with EPS Growth
- Cerus Reports Q1 2026 Earnings, Raises Revenue Guidance
- Amgen Reports Q1 2026 Earnings with Mixed Performance Across Product Lines
- AbbVie Inc. Reports Strong Q1 2026 Earnings with Growth in Immunology and Neuroscience